Celtic PLC
21 November 2007
Celtic plc
Significant shareholding
21 November 2007
Celtic plc has today, 21 November 2007, received notification on behalf of Mr
John Keane under DTR 5.1.2R that on 16 November 2007 Mr Keane acquired 1,426,000
Ordinary Shares of 1p each and 100,000 Convertible Preferred Ordinary Shares of
100p each in the capital of the Company.
Prior to the transactions Mr Keane was interested in 4.99% of the voting rights
in the Company, consisting of interests directly in 4,474,747 Ordinary Shares of
1p each (4.38% of voting rights) and indirectly in 625,000 Convertible Preferred
Ordinary Shares of 100 p each (0.61% of voting rights), calculated on the basis
of the issued voting capital announced at the end of October 2007.
Following the transactions, Mr Keane is interested in 6.488% of the voting
rights in the Company, consisting of direct interests in 5,900,747 Ordinary
Shares ( 5.78% of voting rights) and 100,000 Convertible Preferred Ordinary
Shares (0.098% of voting rights) in his own name and in the name of J Keane
Nominees, and an indirect interest in 625,000 Convertible Preferred Ordinary
Shares of 100p each (0.61% of voting rights ) in Hanom 1 Limited.
End.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.